Twenty-four-week anti-PD-1 antibody regimen promoted HBsAg reduction and concurrently enhanced HBV-specific T cell responses in patients with chronic hepatitis B
Authors
Taiyu He (ORCID: https://orcid.org/0000-0002-4420-6364)
Twenty-four-week anti-PD-1 antibody regimen promoted HBsAg reduction and concurrently enhanced HBV-specific T cell responses in patients with chronic hepatitis B
Taiyu He, L Zhang, Huidan Sun, Dachuan Cai et al.
Journal
Gut
Topics
Hepatitis B Virus Studies
article
Twenty-four-week anti-PD-1 antibody regimen promoted HBsAg reduction and concurrently enhanced HBV-specific T cell responses in patients with chronic hepatitis B
Taiyu He, L Zhang, Huidan Sun, Dachuan Cai, Mingli Peng, Xiaofeng Shi, Ning Ling, Min Chen, Hong Ren, Hua He, Yinghua Lan, Weiqun Zeng, Peng Hu, Aoyi Li, Maoying Liu, Dazhi Zhang